FR2128467A1 - Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen - Google Patents

Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen

Info

Publication number
FR2128467A1
FR2128467A1 FR7207042A FR7207042A FR2128467A1 FR 2128467 A1 FR2128467 A1 FR 2128467A1 FR 7207042 A FR7207042 A FR 7207042A FR 7207042 A FR7207042 A FR 7207042A FR 2128467 A1 FR2128467 A1 FR 2128467A1
Authority
FR
France
Prior art keywords
sulphate
antigen
agents
polymers
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7207042A
Other languages
English (en)
French (fr)
Other versions
FR2128467B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2128467A1 publication Critical patent/FR2128467A1/fr
Application granted granted Critical
Publication of FR2128467B1 publication Critical patent/FR2128467B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR7207042A 1971-03-02 1972-03-01 Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen Granted FR2128467A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712110488 DE2110488A1 (de) 1971-03-02 1971-03-02 Mittel zur Induzierung einer fruehzeitigen,langanhaltenden und erhoehten Immunitaet sowie Verfahren zur Induzierung der Antikoerperbildung durch Verwendung dieses Mittels

Publications (2)

Publication Number Publication Date
FR2128467A1 true FR2128467A1 (en) 1972-10-20
FR2128467B1 FR2128467B1 (https=) 1975-02-07

Family

ID=5800577

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7207042A Granted FR2128467A1 (en) 1971-03-02 1972-03-01 Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen

Country Status (8)

Country Link
AT (1) AT312801B (https=)
BE (1) BE780131A (https=)
DE (1) DE2110488A1 (https=)
ES (1) ES400162A1 (https=)
FR (1) FR2128467A1 (https=)
IL (1) IL38861A0 (https=)
NL (1) NL7202806A (https=)
ZA (1) ZA721224B (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995002688A1 (en) * 1993-07-16 1995-01-26 Chiron Viagene, Inc. Methods and compositions for the removal of viruses and uses thereof
WO2001049320A3 (en) * 2000-01-05 2002-01-17 Cambridge Biopolymers Ltd Use of hemicellulose microparticles as vaccine adjuvant
CN106573057A (zh) * 2014-08-04 2017-04-19 日东电工株式会社 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995002688A1 (en) * 1993-07-16 1995-01-26 Chiron Viagene, Inc. Methods and compositions for the removal of viruses and uses thereof
WO2001049320A3 (en) * 2000-01-05 2002-01-17 Cambridge Biopolymers Ltd Use of hemicellulose microparticles as vaccine adjuvant
CN106573057A (zh) * 2014-08-04 2017-04-19 日东电工株式会社 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物
EP3178495A4 (en) * 2014-08-04 2018-01-17 Nitto Denko Corporation Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug
US10456464B2 (en) 2014-08-04 2019-10-29 Nitto Denko Corporation Liquid immunity induction-promoting composition and vaccine pharmaceutical composition that include thrombosis treatment drug
CN106573057B (zh) * 2014-08-04 2021-01-08 日东电工株式会社 含有血栓症治疗药的体液免疫诱导促进组合物及疫苗药物组合物

Also Published As

Publication number Publication date
ES400162A1 (es) 1974-12-16
FR2128467B1 (https=) 1975-02-07
AT312801B (de) 1974-01-25
IL38861A0 (en) 1972-04-27
NL7202806A (https=) 1972-09-05
DE2110488A1 (de) 1972-09-07
BE780131A (fr) 1972-09-04
ZA721224B (en) 1972-11-29

Similar Documents

Publication Publication Date Title
Lindsay et al. Toxic Properties of a Synthetic Double-stranded RNA: Pyrogenicity of Poly I. Poly C in Rabbits
Feldmann et al. The requirement of macrophages in the secondary immune response to antigens of small and large size in vitro
Tipping et al. Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis
IE37187L (en) Immunological adjunants for vaccines
Weinstein et al. Effect of types of treatment on development of antistreptolysin in patients with scarlet fever.
FR2128467A1 (en) Agents for inducing immune response - contg sulphate esters of polymers and reduced amounts of antigen
Pennington Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis
IT967048B (it) Copolimeri alternati di etilene alchil acrilati e monomeri con centri di vulcanizzazione e pro cesso per la loro preparazione
CN112516169A (zh) 一种用于治疗肠炎的间充质干细胞及其制备方法
Godrick et al. A comparison of the immune response of tonsils with the appendix and spleen in neonatal rabbits
Katano et al. Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice
NL930117I1 (nl) Samenstelling voor verbeterde adsorptie van verschillende kationen
IL40123A (en) 2-amino-4-phenyl-2-imidazolines and pharmaceutically acceptable acid addition salts thereof and methods for their preparation
Moya et al. Immunomodulatory activity of isoprinosine on experimental viral infections in avian models
Bocanegra et al. Convalescent burn plasma therapy for severely burned children. Control study of 81 cases and tests for Pseudomonas antibodies
Dobbs et al. Enhancement of antibody production after treatment with actinomycin-D: interrelationships between 7S and 19S antibody
FR2287912A1 (fr) Derives de polysaccharide portant des groupements amines, leurs procedes de preparation et leurs applications en tant qu'agents adjuvants de l'immunite non specifique
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
GB665405A (en) Improvements in contractable bands for securing glass and other closures to the mouths of reflectors and kindred articles
Hormaeche et al. A New Salmonella Type, Salmonella carrau, with Special Reference to the 1, 7... Phases of the Kauffmann-White Classification
PHILLIPS et al. The Baltimore Anesthesia Study Committee Organization and Preliminary Report
USD188335S (en) Beaded toy train
Nandi Lack of resistance of adult mice to erythrocyte-borne Bittner virus
Lutsik The treatment of meningococcemia by preserving immune homeostasis
KR900011788A (ko) 항-hiv 활성을 지니는 헤파린 분획물

Legal Events

Date Code Title Description
ST Notification of lapse